跳至主要内容
临床试验/NCT03085472
NCT03085472Unknown不适用

Chongqing Intracerebral Hemorrhage Study

First Affiliated Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年2月16日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
hematoma volume growth at 24 hours

研究概览

简要总结

The Chongqing intracerebral hemorrhage study is a multi-center, prospective, observational study led by professor Qi Li from Chongqing Medical University. Professor Peng Xie will be the senior consultant for the study. The Chongqing intracerebral hemorrhage study will focus on the epidemiology, natural history, pathogenesis, laboratory, radiological aspects, clinical outcomes and the effects of treatment in patients with intracerebral hemorrhage.

The clinical, laboratory, imaging, genetic and outcome data of patients diagnosed with acute intracerebral hemorrhage will be prospectively collected. The prognosis of patients with intracerebral hemorrhage will be assessed by using several outcome measure scales at different time points.

详细描述

The Chongqing intracerebral hemorrhage study will try to address several key issues in ICH. The baseline clinical data including demographic, disease severity scores, prior drug history and relevant medical history, premorbid mRS scores will be prospectively recorded. The admission and follow-up imaging data of all registered patients will be saved as Dicom format for future use and review. The functional outcomes will be assessed and recorded by experienced neurologists.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >= 18 years
  • Informed consent to participate in the study
  • Patients diagnosed with CT-confirmed spontaneous Intracerebral Hemorrhage (ICH)
  • Patients are willing to participate in the follow up assessment

排除标准

  • Did not agree to participate in the study
  • Secondary ICH to hemorrhagic infarction or tumor bleeding etc.
  • Traumatic ICH

结局指标

主要结局

hematoma volume growth at 24 hours

时间窗: 24 hours

To assess early hematoma volume growth at 24 hours

次要结局

  • functional outcome at 3 months assessed by modified Ranking Scale(3 months)
  • early neurological deterioration assessed by NIHSS at 48 hours(48 hours)
  • early neurological deterioration assessed by NIHSS score(72hours)
  • perihematoma edema volume measurement at 24 hours(24 hours)
  • perihematoma edema volume measurement at 72 hours(72 hours)
  • intraventricular hemorrhage growth(24 hours)
  • major thromboembolic events(2 weeks)
  • early neurological deterioration assessed by NIHSS score at 24 hours(24 hours)

研究者

发起方
First Affiliated Hospital of Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qi Li

Professor

First Affiliated Hospital of Chongqing Medical University

研究点 (1)

Loading locations...

相似试验